Assessment of asthma treatment against SARS CoV-2 by using a computer approach

Halima Hajji,Tahar Lakhlifi,Khalil El Khatabi,Mohammed Bouachrine,Lhossain Hajji,Hanane Zaki,Fatima En-Nahli,Mohammed Aziz Ajana,S Bourekkadi,H Hami,K Slimani,A Soulaymani,A Mokhtari

doi:10.1051/e3sconf/202131901024

Abstract

The disease caused by the coronavirus is called COVID-19. The degree of infection varies from one person to another. According to the data collected to date, people with asthma and obesity are over-represented among adults hospitalized for COVID-19. The reason is very simple: COVID-19 is a disease that particularly attacks the respiratory system, including the lungs. This pandemic has led us to return to plants. Modern medicine has found its success thanks to traditional medicine, the effectiveness of which comes from medicinal plants. Currently, in China, many people believe in the miraculous power of plants, boosting their immunity to protect against asthma. Therefore, this work aimed to study components of natural origin that have an anti-asthma effect that can be considered as the panacea against Covid-19, by using the most important method, which is molecular docking. In this research, we performed a molecular docking study on molecules naturally occurring molecules based on the recently crystallized SARS CoV-2 protein (pdb code 7C6S). ADMET prediction was performed for the selected inhibitors. The results of molecular docking and ADMET prediction support the potential of the five selected molecules to be further developed as novel inhibitors for the treatment of SARS CoV-2.

Highlights

Nowadays, respiratory diseases are a huge public health burden and the currently well-known diseases are asthma and Covid-19
At the beginning of the SARS-COV-2 coronavirus pandemic [4], the medical professionals were really afraid of seeing too many asthma patients infected with the virus because, as we know, COVID-19 is caused by a virus that directly affects the lungs, so they share several symptoms
We focused on the issue of asthma and covid-19

Summary

Introduction

Respiratory diseases are a huge public health burden and the currently well-known diseases are asthma and Covid-19. At the beginning of the SARS-COV-2 coronavirus pandemic [4], the medical professionals were really afraid of seeing too many asthma patients infected with the virus because, as we know, COVID-19 is caused by a virus that directly affects the lungs, so they share several symptoms. There are exceptions for people with asthma if they have relatively severe asthma that is poorly controlled and is a possible component of Chronic Obstructive Pulmonary Disease (COPD). In these cases, they may be more at risk of having complications from a more severe COVID-19 disease [8]

Objectives

Methods

Results

Conclusion